Sp451
IBD
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
This session brings together UEG member experts to provide a broad overview highlighting the best of abstracts presented at UEG Week 2022.
This session brings together UEG member experts to provide a broad overview highlighting the best of abstracts presented at UEG Week 2022.
Presenter
Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven
Tracks
Related Products
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
AN IMBALANCE IN ACTIVE EOSINOPHILS, T HELPER 1, T HELPER 2 AND REGULATORY T CELLS CHARACTERISES FIBROSTRICTURING CROHN'S DISEASE
BACKGROUND: Mesenteric fat is increasingly believed to exert an important influence on intestinal inflammation. A hallmark of severe Crohn's disease (CD) is the accumulation of mesenteric fat around the inflamed intestine, typically in the terminal ileum…
ENGINEERED HIGH ACETATE PRODUCING SACCHAROMYCES BOULARDII ATTENUATES INFLAMMATION AND SHOWS DOSE-DEPENDENT HISTOLOGIC IMPROVEMENT IN DSS-INDUCED COLITIS
A key feature in intestinal immunity is the dynamic intestinal barrier, which separates the host from resident and pathogenic microbiota through a mucus gel impregnated with antimicrobial peptides…
